Increased asprosin is associated with non-alcoholic fatty liver disease in children with obesity

Asprosin serum levels and glucose homeostasis in children with obesity

(2021) Domenico Corica et al.   CYTOKINE

Increased Serum Circulating Asprosin Levels in Children with Obesity

(2020) Eda Sünnetçi Silistre et al.   PEDIATRICS INTERNATIONAL

Circulating asprosin levels are increased in patients with type 2 diabetes and associated with early-stage diabetic kidney disease

(2020) Hongyu Zhang et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Serum concentration of asprosin in new-onset type 2 diabetes

(2020) Shakiba Naiemian et al.   Diabetology & Metabolic Syndrome

Assessment of acute aerobic exercise in the morning versus evening on asprosin, spexin, lipocalin-2, and insulin level in overweight/obese versus normal weight adult men

(2020) Halil İbrahim Ceylan et al.   CHRONOBIOLOGY INTERNATIONAL

Combination of asprosin and adiponectin as a novel marker for diagnosing non-alcoholic fatty liver disease

(2020) Fan Ke et al.   CYTOKINE

Asprosin impairs insulin secretion in response to glucose and viability through TLR4/JNK-mediated inflammation

(2019) Taeseung Lee et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

The serum level of irisin, but not asprosin, is abnormal in polycystic ovary syndrome patients

(2019) Chia Lin Chang et al.   Scientific Reports

OLFR734 Mediates Glucose Metabolism as a Receptor of Asprosin

(2019) Erwei Li et al.   Cell Metabolism

Decreased Circulating Levels of Asprosin in Obese Children

(2019) Wenjun Long et al.   Hormone Research in Paediatrics

Serum Asprosin Concentrations Are Increased and Associated with Insulin Resistance in Children with Obesity

(2019) Min Wang et al.   ANNALS OF NUTRITION AND METABOLISM

Increased serum level and impaired response to glucose fluctuation of asprosin is associated with type 2 diabetes mellitus

(2019) Xinyue Zhang et al.   Journal of Diabetes Investigation

Asprosin: a novel peptide hormone related to insulin resistance in women with polycystic ovary syndrome

(2018) Murat Alan et al.   GYNECOLOGICAL ENDOCRINOLOGY

Serum asprosin levels and bariatric surgery outcomes in obese adults

(2018) Chao-Yung Wang et al.   INTERNATIONAL JOURNAL OF OBESITY

Acute Anaerobic Exercise Affects the Secretion of Asprosin, Irisin, and Other Cytokines – A Comparison Between Sexes

(2018) Magdalena Wiecek et al.   Frontiers in Physiology

Asprosin is a centrally acting orexigenic hormone

(2017) Clemens Duerrschmid et al.   NATURE MEDICINE

Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride

(2017) Lei Zhang et al.   CLINICA CHIMICA ACTA

Asprosin, a Fasting-Induced Glucogenic Protein Hormone

(2016) Chase Romere et al.   CELL

The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis

(2015) Emma L. Anderson et al.   PLoS One

Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease

(2014) Kouichi Miura   WORLD JOURNAL OF GASTROENTEROLOGY

Pediatric non-alcoholic fatty liver disease: an increasing public health issue

(2013) S. Berardis et al.   EUROPEAN JOURNAL OF PEDIATRICS

Diagnosis of Nonalcoholic Fatty Liver Disease in Children and Adolescents

(2012) Pietro Vajro et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION